Last reviewed · How we verify
NCT04863391
Telemedicine in Age-Related Macular Degeneration
trial testing Referrable versus Non Referral AMD diagnostic test in Age Related Macular Degeneration in 1,000 participants. Status unknown.
19 July 2022
Quick facts
| Lead sponsor | The New York Eye & Ear Infirmary |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 19 July 2020 |
| Primary completion | 19 July 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Referrable versus Non Referral AMD diagnostic test
Conditions studied
- Age Related Macular Degeneration — all drugs for Age Related Macular Degeneration →
Sponsor
The New York Eye & Ear Infirmary — full company profile →
Who can join
50 and older, any sex, with Age Related Macular Degeneration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study seeks to evaluate a system for the automated early detection of Age-Related Macular Degeneration (AMD). AMD is a condition in which there is breakdown of the macula of the eye, the part of the retina that is responsible for sharp, central vision. We will take pictures of subjects' eyes using an automated camera. These photographs will be securely transmitted and and then analyzed by a computer program which has been developed in other studies. The outcome of the computer program analysis will be compared with human analysis of these same pictures. If the computer analysis is has good enough accuracy, then this computer system could be used for wide-scale screening for AMD.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
AI-based support for optical coherence tomography in age-related macular degeneration.
Mares V, Nehemy MB, Bogunovic H, Frank S, et al · · 2024 · cited 16× · PMID 38589936 · DOI 10.1186/s40942-024-00549-1
Verify or expand the search:
- PubMed search for NCT04863391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Age Related Macular Degeneration
Currently open trials in the same condition.
- NCT07461441 — Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal · Phase 3 · recruiting
- NCT07235527 — Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degener · recruiting
- NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience · NA · recruiting
- NCT03102138 — Retinal Pigment Epithelium Safety Study for Patients in B4711001 · active not recruiting
- NCT05698316 — A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Predicti · active not recruiting
Other The New York Eye & Ear Infirmary trials
Trials by the same sponsor.
- NCT05324189 — Automated AI-based System for Early Diagnosis of Diabetic Retinopathy · unknown
- NCT04087356 — Age-related Macular Degeneration (AMD) and Cardiovascular Disease · unknown
- NCT03918590 — Post Intravitreal Injection Topical NSAID vs. Patching · Phase 4 · unknown
- NCT02984813 — Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy · Phase 1 · terminated
- NCT02990143 — The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve · Phase 2 · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04863391 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The New York Eye & Ear Infirmary
- Last refreshed: 28 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04863391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing